Written by Steven Hansen
The U.S. new cases 7-day rolling average are 23.9 % LOWER than the 7-day rolling average one week ago. U.S. hospitalizations due to COVID-19 are now 12.6 % LOWER than the rolling average one week ago. U.S. deaths due to coronavirus are now 3.7 % LOWER than the rolling average one week ago. Today’s posts include:
- U.S. Coronavirus New Cases are 94,704
- U.S. Coronavirus hospitalizations are at 76,979
- U.S. Coronavirus deaths are 3,364 [are the new variants more deadly or are vaccinations increasing deaths – as deaths are no longer correlating with new cases or hospitalizations?>
- U.S. Coronavirus immunizations have been administered to 13.4 % of the population
- The 7-day rolling average rate of growth of the pandemic shows new cases improved, hospitalizations little changed, and deaths improved
- Hopefully, these current improving COVID trends will remain in play even with the new strains
- Experimental Covid drug cures 30 out of 30 moderate to severe cases in Phase I clinical trial at Israeli hospital.
- The pandemic is in retreat for now
- Study shows anti-inflammatory drug reduces risk of death in hospitalized COVID patient
- COVID Vaccine Side Effects, Distrust Leave 30% of Americans Skeptical of Getting It
- 3M is helping authorities stop the sale of counterfeit versions of its N95 masks
- A new diplomatic currency: Covid-19 vaccines
The recent worsening of the trendlines for new cases is behind us which was attributed to going back to college/university, cooler weather causing more indoor activities, mutation of the virus, fatigue from wearing masks / social distancing, holiday activities, and some loosening of regulations designed to slow the coronavirus spread.
My continuing advice is to continue to wash your hands (especially after using the toilet as COVID first sheds in your stool), putting down the toilet seat (as flushing the toilet releases a plume), wear masks, avoid crowds, and maintain social distancing. No handwashing, mask, or social distancing will guarantee you do not get infected – but it sure as hell lowers the risk in all situations – and the evidence to-date shows a lower severity of COVID-19. In addition, certain activities are believed to carry a higher risk – like being inside in air conditioning and removing your mask (such as restaurants, around your children/grandchildren, bars, and gyms). It is all about viral load – and outdoor activities are generally safe if you can maintain social distance. Finally, studies show eating right (making sure you are supporting your immune system) and adequate sleep increase your ability to fight off COVID.
include($_SERVER[‘DOCUMENT_ROOT’].’/pages/coronavirus1.htm’); ?>
Hospitalizations (grey line) and Mortality (green line)
source: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html
Hospitalizations Are The Only Accurate Gauge As Reporting Is Not Affected By Holidays
The 4 day Thanksgiving holiday period put the first wobble in the trends. Over weekends and holidays, the number of new cases and deaths decline. Over weekends, this is not a problem for week-over-week rolling averages as weekends are compared against the previous weekend. But when a holiday falls within a working week, a non-working day is compared to a working day which causes havok in the trends.
However, hospitalizations historically appear to be little affected by weekends or holidays – the daily counts do not vary significantly from day-to-day.
The hospitalization growth rate trend is improving.
For the Thanksgiving and the end of the year holiday period – roughly, it seems each appears to have added around 5 % to the rate of growth of new cases, hospitalizations, and deaths.
Historically, hospitalization growth follows new case growth by one to two weeks.
As an analyst, I use the rate of growth to determine the trend. But, the size of the pandemic is growing in terms of real numbers – and if the rate of growth does not become negative – the pandemic will overwhelm all resources.
The graph below shows the rate of growth relative to the growth a week earlier updated through today [note that negative numbers mean the rolling averages are LOWER than the rolling averages one week ago]. As one can see, the rate of growth for new cases peaked in early December 2020 for Thanksgiving, and early January 2021 for end of year holidays – and the rate of growth is now contracting.
In the scheme of things, new cases decline first, followed by hospitalizations, and then deaths.
It is up to each of our readers to protect themselves and others by washing your hands, wearing a mask, avoiding crowds, and maintaining social distancing.
Will The New Variants Cause The Next Spike?
Maybe and maybe not. It all depends on vaccinations:
- the more people that are vaccinated reduces the pool of people that can be infected. Today we have removed over 13 % of the population from being infected which theoretically should reduce the infection rate by 13 % [it is unstudied whether the vaccines prevent a vaccinated person from being a carrier of the virus even though showing no signs]. If the vaccines are shown to stop transmission, then in theory it would reduce the infection rate by double the percent vaccinated [in this case you prevent your own infection and do not pass it along to another].
- it is also unknown what the effective rate of the current vaccines is against mutations that seem to appear almost daily. As an example, if the effective rate drops to 60%, it means the 13 % reduction in the infection rate discussed above is almost cut in half. The South African and Brazilian variant is somewhat immune to the current vaccines.
- The pandemic should be over immediately if everyone could be vaccinated today. The problem is that every day brings a new mutation (which would not appear if the pandemic was stopped). The longer the immunization process takes – the more ineffective the vaccine will become.
- It is not clear whether the vaccine prevents those vaccinated from spreading the virus. It seems to be well documented that it normally stops the virus from taking hold and when it does not – the infection is mild.
Coronavirus News You May Have Missed
The pandemic is in retreat – New York Times
The number of new coronavirus cases continues to plummet, as does the number of Americans hospitalized with symptoms. Deaths have also begun to decline. And the number of daily vaccination shots has nearly tripled over the last month.
It’s been a long time since the virus news was as encouraging as it is right now.
The overall situation is still bad. The virus is spreading more rapidly in the U.S. than in almost any other large country, and more than 2,500 Americans are dying daily. Newly contagious variants may create future outbreaks. For now, though, things are getting better – and a combination of vaccinations, mask-wearing and social distancing has the potential to sustain the recent progress.
… We’re slowly building immunity
The main cause of the decline appears to be that a significant share of people now have at least some immunity to the virus. That also helps explain the global decline in newly diagnosed cases:
In the U.S., about 110 million people have likely had the virus (including unconfirmed cases), researchers say. Another 33 million have received at least one vaccine shot.
Combined, these two groups make up about 43 percent of all Americans, which appears to be enough to slow the spread. “Though it is difficult to know for sure,” Andrew Brouwer, a University of Michigan epidemiologist, told The Wall Street Journal, “we may be approaching herd protection.”
Still, this protection does not ensure a continuing decline in cases. Most Americans still haven’t had the virus.
Has Israel just found the cure for Covid? – Israel21
Experimental Covid drug cures 30 out of 30 moderate to severe cases in Phase I clinical trial at Israeli hospital.
EXO-CD24, an experimental inhaled medication developed at Tel Aviv Sourasky Medical Center, cured all 30 moderate-to-severe cases in a Phase I clinical trial.
Developed over the past six months at the hospital, EXOCD24 stops the “cytokine storm” – where the immune system goes out of control and starts attacking healthy cells – that occurs in the lungs of 5-7% of Covid-19 patients.
“To date, the preparation has been tried with great success on 30 severe patients, in 29 of whom the medical condition improved within two to three days and most of them were discharged home within three to five days. The 30th patient also recovered but after a longer time,” the hospital reports.
“The drug is based on exosomes, [vesicles] that are released from the cell membrane and used for intercellular communication. We enrich the exosomes with 24CD protein. This protein is expressed on the surface of the cell and has a known and important role in regulating the immune system,” explained Dr. Shiran Shapira, director of the laboratory of Prof. Nadir Arber, who has been researching the CD24 protein for over two decades.
“The preparation is given by inhalation, once a day, for only a few minutes, for five days,” Shapira said.
She said the experimental treatment has two unique characteristics. The first is that it inhibits the over-secretion of cytokines. The second is that it is delivered directly to the lungs and therefore has no systemic side effects that injected or oral drugs can cause.
“Even if the vaccines perform their function, and even if no new mutations are produced then still in one way or another the corona will remain with us,” said Arber, director of the medical center’s Integrated Cancer Prevention Center. “To this end, we have developed a unique drug, EXO-CD24.”
Study shows anti-inflammatory drug reduces risk of death in hospitalized COVID patients – The Hill
An anti-inflammatory drug used to treat rheumatoid arthritis reduces the risk of death in hospitalized patients with severe COVID-19, especially when combined with the steroid dexamethasone, according to results of a study released Thursday.
Tocilizumab, an intravenous drug manufactured by Roche, was also shown to reduce the need for a mechanical ventilator and shorten the length of hospitalization.
The preliminary results came from the Recovery trial at the University of Oxford, which has been studying various potential treatments for COVID-19 since March.
Tocilizumab, sold under the brand name Actemra, was added to the trial in April for patients with COVID-19 who required oxygen and had evidence of inflammation.
“Previous trials of tocilizumab had shown mixed results, and it was unclear which patients might benefit from the treatment,” Peter Horby, a professor at the University of Oxford and joint chief investigator for the Recovery trial, said in a statement.
“We now know that the benefits of tocilizumab extend to all COVID patients with low oxygen levels and significant inflammation. The double impact of dexamethasone plus tocilizumab is impressive and very welcome,” Horby said.
COVID Vaccine Side Effects, Distrust Leave 30% of Americans Skeptical of Getting It: Poll – Newsweek
Roughly 1 in 3 Americans said they will definitely or probably not receive the coronavirus vaccine, mostly because of distrust and concerns that the shot could lead to unpleasant side effects, according to a new poll.
The survey, which was conducted by the Associated Press-NORC Center for Public Affairs Research and published Wednesday, found that at least 30 percent of respondents have indicated that they definitely will not, or probably will not, receive the inoculation.
Among those surveyed, 15 percent said they were certain they won’t get vaccinated, while 17 percent said they probably won’t.
According to the results, skepticism was found to run higher among younger people, people without college degrees, Black Americans and Republicans.
Among those who indicated they would definitely not receive the shot, 65 percent said they were concerned about side effects and reported feeling distrust about the vaccine. An additional 38 percent said they don’t believe they need a vaccine, while a similar percentage said that they don’t know if a COVID-19 vaccine would be effective.
For those who indicated they probably will not receive the vaccine, 63 percent said they are still waiting to see if it is safe, while 60 percent said they are concerned about side effects.
A new diplomatic currency: Covid-19 vaccines. – New York Times
It’s one of the world’s most in-demand commodities and has become a new currency for international diplomacy: Countries with the means or the know-how are using coronavirus vaccines to curry favor or thaw frosty relations.
India, the unmatched vaccine manufacturing power, is giving away millions of doses to neighbors friendly and estranged. It is trying to counter China, which has made doling out shots a central plank of its foreign relations. And the United Arab Emirates, drawing on its oil riches, is buying shots on behalf of its allies.
But the strategy carries risks.
India and China have vast populations of their own that they need to inoculate. Although there are few signs of grumbling in either country, that could change as the public watches doses be sold or donated abroad.
“Indians are dying. Indians are still getting the disease,” said Manoj Joshi, a distinguished fellow at the Observer Research Foundation, a New Delhi think tank. “I could understand if our needs had been fulfilled and then you had given away the stuff. But I think there is a false moral superiority that you are trying to put across where you say we are giving away our stuff even before we use it ourselves.”
For India, its soft-power vaccine drive has given it a rejoinder to China after years of watching the Chinese make political gains in its own backyard – in Sri Lanka, the Maldives, Nepal and elsewhere. Beijing offered deep pockets and swift answers when it came to big investments that India, with a layered bureaucracy and slowing economy, has struggled to match.
So India has sent vaccine doses to Nepal, a country that has fallen increasingly under China’s influence. And Sri Lanka, in the midst of a diplomatic tug of war between New Delhi and Beijing, is getting doses from both.
The donating countries are making their offerings at a time when the United States and other rich nations are scooping up the world’s supplies. Poorer countries are frantically trying to get their own, a disparity that the World Health Organization recently warned has put the world “on the brink of a catastrophic moral failure.”
With their health systems tested as never before, many countries are eager to take what they are offered – and the donors could reap some political good will in reward.
“Instead of securing a country by sending troops, you can secure the country by saving lives, by saving their economy, by helping with their vaccination,” said Dania Thafer, the executive director of the Gulf International Forum, a Washington-based think tank.
Still, efforts to use vaccines to win hearts and minds aren’t always successful.
3M is helping authorities stop the sale of counterfeit versions of its N95 masks – CNBC
Industrial giant 3M has been working around the clock with law enforcement to help stop the sale of millions of counterfeit versions of its N95 mask.
“We have taken very strong steps around attacking the problems of counterfeiting or price gouging. And that has occurred over the last year in this constrained supply and very strong demand environment on critical products such as the N95,” Mike Vale, who leads 3M’s safety and industrial business group, told CNBC in a story that ran Wednesday evening on “The News with Shepard Smith.”
N95s have been the gold standard during the coronavirus pandemic for their ability to filter out at least 95% of airborne particles. The masks, which are seen as critical in protecting front-line workers from Covid-19, have been in short supply. 3M is the largest N95 manufacturer.
Federal authorities announced Wednesday that scammers have distributed millions of fake N95s to health-care workers in at least five states. So far, 11,000 cases of the counterfeit masks have been reported by 3M, leading to 29 civil lawsuits. In total, the company said it’s seized 10 million fake N95s. In mid-January, 3M helped its home state of Minnesota avoid buying nearly 500,000 counterfeit N95s from a Florida company. 3M sued and ended up winning an injunction.
A new coronavirus mutation known as the Bristol variant might “infect people who were previously infected, or have been previously vaccinated,” Professor John Edmunds, a member of the UK government’s Scientific Advisory Group for Emergencies (SAGE) said Thursday.
“I don’t know whether the Bristol variant is any more transmissible than the Kent variant. I suspect it isn’t,” Edmunds told ITV News.
“Where it has an advantage — potentially at least — is that it may be able to infect people who were previously infected, or have been previously vaccinated. That’s the worry with that particular virus.”
New variants of coronavirus have now been identified in the English cities of Bristol, Liverpool and Manchester, UK Health Secretary Matt Hancock said in a statement Wednesday.
Hancock reiterated the government’s commitment to using enhanced contact tracing, surge testing and genomic sequencing to monitor community spread of the new strains.
Some context: Public Health England has said that cases found in Bristol are the new UK variant with the E484K mutation, which has already been identified in the South African and Brazilian variants of the virus. The mutation could allow Covid-19 to escape antibody protection.
[editor’s note: On the original Kent UK variant UK variant is “going to sweep the world” says head of genetic surveillance program]
Fauci: April should be ‘open season’ for vaccinations – The Hill
Anthony Fauci said he thinks that by April it will be “open season” for vaccinations in the country, and anyone who wants a shot will be able to get one.
Speaking on NBC’s “Today,” Fauci, the nation’s top infectious diseases doctor and science adviser to President Biden, predicted the rate of vaccinations will pick up in the spring as more doses become available and more locations start administering shots.
He said the pace will increase because of the administration’s programs to allow pharmacies and community health centers to administer shots.
“I would imagine by the time we get to April, that would be what I call … open season. Namely, virtually everybody and anybody in any category can start to get vaccinated,” Fauci said.
However, he added that it will still take “several more months” to get the vaccine into people’s arms, but that hopefully the overwhelming majority of people in this country will be vaccinated by the end of the summer.
While the pace has picked up to about 1.5 million people a day, the nation’s vaccine rollout has been uneven, plagued by supply shortages and differing approaches in every state.
There are only two companies with authorized vaccines in the U.S., but Johnson & Johnson is set for federal review at the end of this month, potentially adding to the available supply as soon as March.
The following are foreign headlines with hyperlinks to the posts
Canada tightens border, to require negative test
Austrian hotspot for South African variant deploys 1,200 troops to contain virus spread
WHO Africa encourages use of AstraZeneca vaccine despite variants
AstraZeneca expects to increase vaccine capacity to more than 200 million doses per month by April
UK is doing all it can to make summer holidays possible, health secretary says
Mexico grants emergency use approval for 2 China-made Covid-19 vaccines
Japan has the most beds per capita in the developed world. So why is its health system crashing?
More than 20% of Covid-19 infections in France caused by UK variant, Health Minister says
The following additional national and state headlines with hyperlinks to the posts
Best Buy to cut undisclosed number of workers as shopping behavior changes amid COVID-19
To defeat the virus, Biden’s team must oversee a herculean logistical effort to put shots into hundreds of millions of arms. It also must overcome vaccine hesitance, politically charged science skepticism and fatigue across all corners of society
U.S. Vaccine Poll: About 1 in 3 Americans say they definitely or probably won’t get the coronavirus vaccine. That’s according to a new poll that some experts say is discouraging news if the U.S. hopes to achieve herd immunity and vanquish the outbreak
Suing U.S. Nursing Homes : As the virus takes a devastating toll on seniors in nursing homes, many attorneys are turning down grieving families seeking to sue long-term care providers for wrongful death. That’s because more than half of U.S. states have granted nursing homes and other health providers protection from lawsuits during the pandemic. The federal government says about 162,000 nursing home residents and workers have died, accounting for roughly 1-in-3 virus deaths in the U.S.
A Third Of All US Homeowners Own Property Worth Double The Underlying Mortgage
California man tests positive for COVID-19 weeks after second jab: report
Medicare Part B covers the COVID-19 vaccine, so there’s no cost to you. When you go to get your vaccine, make sure to bring your Medicare card, so the vaccine provider can bill Medicare.
Double masking: Type of masks are key
Wear at least one mask, but double masking helps get a tighter fit, says Fauci
CVS, Walgreens to begin COVID-19 vaccinations Friday
The CDC now says most people who have received their full COVID vaccine course don’t need to quarantine after exposure to an infected person.
Poll indicates one-third of the U.S. population says they probably or definitely won’t get the COVID-19 vaccine.
Two COVID cases involving the so-called South African variant (B.1.351) turned up in California.
The NIH said pregnant and lactating people should be included in COVID-19 vaccine clinical trials.
Around two dozen cases of thrombocytopenia have been reported after COVID vaccination, but researchers can’t find a mechanistic link.
CDC: Double Mask Up to Reduce COVID Exposure
Boosted jobless benefits did little to discourage workers from finding jobs: study
Fauci: Vaccines for Kids Could Be Authorized by September
Florida COVID Travel Advice As State Records Over 300 Cases of New Variant
40% of U.S. COVID Deaths Could Have Been Averted If It Weren’t for Trump
Massachusetts will vaccinate companions who accompany older people to appointments.
As Congress tries to help streamline Covid-19 vaccine distribution and provide more relief to jobless Americans, House Speaker Nancy Pelosi expects the next pandemic aid bill to become law within weeks.
An ongoing semiconductor chip shortage is expected to cut $60.6 billion in revenue from the global automotive industry this year, according to consulting firm AlixPartners.
A $15 minimum wage is back in the pandemic relief package. What you need to know
California overtakes New York as US state with most Covid-19 deaths
Today’s Posts On Econintersect Showing Impact Of The Pandemic With Hyperlinks
06 February 2021 New York Fed Weekly Economic Index (WEI): Index Modest Decline Continues
6 February 2021 Initial Unemployment Claims Rolling Average Improves
The Pre-Pandemic Debt Landscape – And Why It Matters
The Impact Of Business Closures On Covid-19 Infection Rates
Why Has Contact Tracing Not Been Effective In The US Pandemic?
Warning to Readers
The amount of politically biased articles on the internet continues to increase. And studies and opinions of the experts continue to contradict other studies and expert opinions. Honestly, it is difficult to believe anything anymore. A studymers Expect Higher Spending and Home Prices Improvement
January 2021 Small Business Optimism Drops Further Below Historical Index Average in January
Infographic Of The usually cannot establish cause and effect – but only correlation. Be very careful what you believe about this pandemic.
I assemble this coronavirus update daily – sifting through the posts on the internet. I try to avoid politically slanted posts (mostly from CNN, New York Times, and the Washington Post) and can usually find unslanted posts on that subject from other sources on the internet. I wait to publish posts on subjects that I cannot validate across several sources. But after all this extra work, I do not know if I have conveyed the REAL facts. It is my job to provide information so that you have the facts necessary – and then it is up to readers to draw conclusions.
Analyst Opinion of Coronavirus Data
There are several takeaways that need to be understood when viewing coronavirus statistical data:
- The global counts are suspect for a variety of reasons including political. Even the U.S. count has issues as it is possible that as much as half the population has had coronavirus and was asymptomatic. It would be a far better metric using a random sampling of the population weekly. In short, we do not understand the size of the error in the tracking numbers.
- Just because some of the methodology used in aggregating the data in the U.S. is flawed – as long as the flaw is uniformly applied – you establish a baseline. This is why it is dangerous to compare two countries as they likely use different methodologies to determine who has (and who died) from coronavirus.
- COVID-19 and the flu are different but can have similar symptoms. For sure, COVID-19 so far is much more deadly than the flu. [click here to compare symptoms]
- From an industrial engineering point of view, one can argue that it is best to flatten the curve only to the point that the health care system is barely able to cope. This solution only works if-and-only-if one can catch this coronavirus once and develops immunity. In the case of COVID-19, herd immunity may need to be in the 80% to 85% range. WHO warns that few have developed antibodies to COVID-19 when recovering from COVID-19. Herd immunity does not look like an option without immunization although there is now a discussion of whether T-Cells play a part in immunity [which means one might have immunity without antibodies]
- Older population countries will have a significantly higher death rate as there is relatively few hospitalizations and deaths in younger age groups..
- There are at least 8 strains of the coronavirus. New York may have a deadlier strain imported from Europe, compared to less deadly viruses elsewhere in the United States.
- Each publication uses different cutoff times for its coronavirus statistics. Our data uses 11:00 am London time. Also, there is an unexplained variation in the total numbers both globally and in the U.S.
What we do or do not know about the coronavirus [actually there is little scientifically proven information]. Most of our knowledge is anecdotal, from studies with limited subjects, or from studies without peer review.
- How many people have been infected as many do not show symptoms?
- Masks do work. Unfortunately, early in the pandemic, many health experts – in the U.S. and around the world – decided that the public could not be trusted to hear the truth about masks. Instead, the experts spread a misleading message, discouraging the use of masks.
- Current thinking is that we develop 5 months of immunity from further COVID infection.
- The Moderna and Pfizer vaccines have an effectiveness rate of about 95 percent after two doses. That is on par with the vaccines for chickenpox and measles. The 95 percent number understates the effectivenessas it counts anyone who came down with a mild case of Covid-19 as a failure. But turning Covid into a typical flu – as the vaccines evidently did for most of the remaining 5 percent – is actually a success. Of the 32,000 people who received the Moderna or Pfizer vaccine in a research trial, only one contracted a severe Covid case.
- To what degree do people who never develop symptoms contribute to transmission? Research early in the pandemic suggested that the rate of asymptomatic infections could be as high as 81%. But a meta-analysis, which included 13 studies involving 21,708 people, calculated the rate of asymptomatic presentation to be 17%.
- The accuracy of rapid testing is questioned – and the more accurate test results are not being given in a timely manner.
- Can children widely spread coronavirus? [current thinking is that they are a minor source of the pandemic spread]
- Why have some places avoided big coronavirus outbreaks – and others hit hard?
- Air conditioning contributes to the pandemic spread.
- It appears that there is increased risk of infection and mortality for those living in larger occupancy households.
- Male patients have almost three times the odds of requiring intensive treatment unit (ITU) admission compared to females.
- Outdoor activities seem to be a lower risk than indoor activities.
- Will other medical treatments for Covid-19 ease symptoms and reduce deaths? So far only remdesivir, Bamlanivimab,
and Regeneron) are approved for treatment. What drugs work? Arthritis drugs tocilizumab and sarilumab could cut relative risk of death of those in intensive care by 24%
- A current scientific understanding of the way the coronavirus works can be found [here].
There is now a vaccine available – the questions remain:
- how effective it will be in the general population,
- will there be any permanent side effects that will appear months from now,
- how long immunity will last [we can currently say we do not know if it will last more than 4 months],
- there is no evidence the vaccine will block transmission
Heavy breakouts of coronavirus have hit farmworkers. Farmworkers are essential to the food supply. They cannot shelter at home. Consider:
- they have high rates of respiratory disease [occupational hazard]
- they travel on crowded buses chartered by their employers
- few have health insurance
- they cannot social distance and live two to four to a room – and they eat together
- some reports say half are undocumented
- they are low paid and cannot afford not to work – so they will go to work sick
- they do not have access to sanitation when working
- a coronavirus outbreak among farmworkers can potentially shutter entire farm
The bottom line is that COVID-19 so far has been shown to be much more deadly than the data on the flu. Using CDC data, the flu has a mortality rate between 0.06 % and 0.11 % Vs. the coronavirus which to date has a mortality rate of 4 % [the 4% is the average of overall statistics – however in the last few months it has been hovering around 1.0%] – which makes it between 10 and 80 times more deadly. The reason for ranges:
Because influenza surveillance does not capture all cases of flu that occur in the U.S., CDC provides these estimated ranges to better reflect the larger burden of influenza.
There will be a commission set up after this pandemic ends to find fault [it is easy to find fault when a once-in-a-lifetime event occurs] and to produce recommendations for the next time a pandemic happens. Those that hate President Trump will conclude the virus is his fault.
Resources:
- Get the latest public health information from CDC: https://www.coronavirus.gov .
- Get the latest research from NIH: https://www.nih.gov/coronavirus.
- Find NCBI SARS-CoV-2 literature, sequence, and clinical content: https://www.ncbi.nlm.nih.gov/sars-cov-2/.
- List of studies: https://icite.od.nih.gov/covid19/search/#search:searchId=5ee124ed70bb967c49672dad
include(“/home/aleta/public_html/files/ad_openx.htm”); ?>